R EGULATION of tyrosine phosphorylation of cellular proteins plays a major role in the control of cell growth, cell differentiation, cell cycle progression, and malignant transformation (1, 2) . In response to stimulation by external ligands, many cellular proteins (e.g. growth factor receptors and cytoplasmic kinases of the Jak and Src families) are phosphorylated on multiple tyrosine residues, resulting in immediate activation of the tyrosine kinases (3, 4) . Indeed, a number of protooncogenes are tyrosine kinases, and the level of kinase activity in the corresponding oncogenes is usually several-fold higher due to constitutive autophosphorylation of tyrosine residues (5). Thus, phosphorylation on tyrosine residues, an early event in mitogenic signal transduction through growth factor receptors, can become an important factor contributing to tumorigenicity and growth of cancer cells. Inhibition of tyrosine phosphorylation has been shown to result in reduced cell proliferation, growth arrest, and cellular apoptosis (4-6). Somatostatin (SST), originally isolated as an endocrine inhibitor of pituitary GH secretion, is now recognized as a hormone capable of regulating such fundamental processes as secretion, cell division, proliferation, and apoptosis (7-12). The actions of SST are mediated by a family of specific SST receptors (SSTR) in a G proteindependent manner and are signalled via multiple cellular effector systems, including CAMP, K+, intracellular Ca'+, phospholipase A,+lipoxygenase, and protein tyrosine phos-phatase (PTP) (for reviews, see Refs. 13 and 14) . PTP induced by SST has been implicated in its antiproliferative actions by virtue of its ability to dephosphorylate and inactivate growth factor receptor kinases (15) (16) (17) (18) OCT did not stimulate PTP activity in the cytosol when added during the enzyme assay (Fig. 3B, closed circles) . By contrast, membrane fractions prepared from cells preincubated with the peptide for 24 h possessed markedly increased PTP activity compared with membranes of control untreated cells. Induction of membrane-associated PTP activity was clearly dependent on the concentration of peptide present in the culture medium, with half-maximal activation observed at 60 PM OCT (Fig. 3A, open circles) . Under these conditions, OCT induced a dose-dependent decrease in the cytosolic enzyme activity (Fig. 3B, ope11 circles) . To determine the time course of the OCT-induced change in the subcellular distribution of PTP activity, we preincubated MCF-7 cells with 10 nM peptide from O-24 h and analyzed the enzyme activity in the membrane and cytosolic fractions. OCT treatment of intact cells induced a rapid and prolonged increase in membrane-associated PTP activity, which was maximal (2.7-fold greater than the control value) by 4 h and remained more than 2-fold higher for up to 24 h (Fig. 3C) . The increase in membrane-associated PTP was accompanied by a timedependent decrease in cytosolic PTP activity, with a maximal 42% decrease by 4 h that was sustained for up to 24 h (Fig.  3D) tion of OCT, Western blot analysis was performed using a rabbit anti-PTPlC antibody.
In untreated MCF-7 cells, the enzyme protein exhibited preferential cytosolic localization. In cells incubated for 4 h with OCT, a concentration-dependent decrease in the intensity of this band was observed in the cytosolic fraction, with a concomitant increase in the membrane fraction (Fig. 4) . The size of this band (66 kDa) was identical to that of PTPlC purified from an adenovirus expression system (21). In cells incubated with 10 nM OCT, the translocation of PTPlC to cell membrane was time dependent. The translocation occurred within minutes, and the amount of PTPlC on membranes reached a maximum by 2 h and remained elevated for up to 24 h (Fig. 5) . Other SST analogs, such as RC-160, also induce redistribution of PTPlC in MCF-7 cells (24) (Srikant, C. B., and S.-H. Shen, unpublished observations).
In contrast to PTPIC, OCT and other SST analogs did not induce translocation of PTP2C to the cell membrane in MCF-7 cells (data not shown). To establish whether OCT-induced augmentation of membrane-associated PTP activity is due to PTPlC, we analyzed the enzyme activity in immunoprecipitates obtained from membrane and cytosolic fractions of MCF-7 cells incubated with OCT using the PTPlC antibody.
Greater than 80% of the PTP activity in the cell membrane was detected in the immuno- cog protein were electrophoresed on 10% polyacrylamide gels, transferred to Protrans membranes, and probed with anti-PTPlC antibody as described in Materials and Methoo!.s. As shown in this representative blot, the enzyme was detected as a 66-kDa protein, principally in the cytosol. In control cells, OCT induced a dose-dependent translocation of the intracellular enzyme to the membrane, as evidenced by the decrease in the intensity of this band in the cytosolic (left pane21 and a concomitant increase in the membrane (middle panel) fractions. The size of the protein band corresponds to the size of the recombinant PTPlC purified from an adenovirus expression system (right panel).
FIG. 5. OCT induces a time-dependent increase
in membrane-associated PTPlC. Thirty micrograms of membrane proteins prepared from cells incubated with 10 nM OCT from 5 min to 24 h were electrophoresed and analyzed as described in Fig. 4 . An OCT-induced increase in membrane-associated PTPlC occurred in minutes, reached a maximum by 2-4 h, and remained elevated for up to 24 h. precipitates, establishing that PTPlC is the principal tyrosine phosphatase translocated by the action of OCT (0.29 +-0.09 nmol/mg in the control compared to 0.55 + 0.13 nmol/mg in cells treated with 10m7 M OCT). This was further confirmed by a corresponding decrease in the activity of PTPlC immunoprecipitates obtained from cytosolic fractions of OCT (10e7 M)-treated cells (0.39 + 0.13 nmol/mg in the control compared to 0.22 2 0.07 nmol/mg in the treated cells).
OCT-induced translocation of PTPlC is inhibited by pertussis toxin and orthovanadate
To determine whether OCT-induced translocation of PTPlC to the cell membrane is G protein dependent, MCF-7 cells were pretreated for 24 h with 100 rig/ml of the toxin and then incubated with 10 nM OCT for 60 min. Pertussis toxin treatment prevented the OCT-induced translocation of cytoplasmic PTPlC to the membrane (Fig. 6, left panel) . This was confirmed by the reversal of the OCT-induced decrease in PTPlC in the cytosolic fraction by pertussis toxin treatment of the cells (Fig. 6, right panel) . As shown in this figure, I I I  I I   kDa   24  8  16 a orthovanadate, a phosphatase inhibitor, also blocked OCTinduced recruitment of PTPlC to the membrane and prevented the OCT-induced decrease in cytosolic PTPlC.
Discussion
In this study, we demonstrated that OCT, an octapeptide SST analog, binds to specific SSTRs in MCF-7 human breast cancer cells and directly inhibits cell growth in a dose-dependent manner. Pertussis toxin, which ADP ribosylates and inactivates G protein(s) linked to SSTR (for review, see Refs. 13 and 14), abolished the inhibitory effect of OCT on cell growth, suggesting that its action is G protein dependent. The fact that orthovanadate, a tyrosine phosphatase inhibitor, reversed OCT-induced growth inhibition in these cells strongly argues that PTP is involved in the SST-induced antiproliferative signal. The inhibition of cell growth by OCT described here substantiates previous reports of an antiproliferative effect of SST analogs in several tumor cells derived from breast, pancreas, pituitary, and thyroid (10-12, 15,17, 2531). The present findings also strengthen the emerging consensus on the mediation by G protein and dependency on a SST-inducible PTP of the antiproliferative action of SST (15, 17, 31, 32) .
OCT did not stimulate PTP activity in MCF-7 cell membranes, in striking contrast to the reported direct activation of PTP by SST at the membrane level in pancreatic tumor cells (17, 33) . On the other hand, preincubation of the cells with the peptide induced a rapid, time-and concentration-dependent net increase in membrane-associated PTP activity. This suggests that upon binding to SSTRs, OCT acts to recruit cytosolic PTP to the cell membrane. Translocation of cytosolic PTP to the membrane in MCF-7 cells by OCT occurred rapidly, was sustained for up to 24 h, and was concentration dependent. These observations are in agreement with the finding of increased membrane-associated PTP in rat pancreatic (AR4-2J) and human colonic tumor (SW620) cells preincubated with SST analogs (34, 35) . Although only a transient increase in membrane-associated PTP activity lasting 60 min or less was observed in these studies, the present data show that in MCF-7 cells preincubated with the peptide, OCT induces a sustained increase, lasting up to 24 h, in PTP activity in membrane fractions.
What is the nature of the cytosolic PTP recruited by SST to the membrane? SST-stimulated PTP was reported to be a 65-to 70-kDa protein based on gel filtration studies (36). Two members of the cytosolic PTP family have been cloned: PTPlC, which is a 66-kDa protein, and PTP2C (also known as SHPTP2 / SHPTP3 / PTPlD / Syp), which has a molecular size of 72 kDa (37, 38) . PTP2C has been shown to function as a positive transducer in receptor tyrosine kinase-induced mitogenic signaling via the mitogen-activated protein (MAP) kinase pathway (39-41) and, as such, is unlikely to mediate the inhibitory action of SST. In studies that will be reported elsewhere, we determined that OCT does not influence the activity or the cellular localization of PTP2C in MCF-7 cells (manuscript in preparation). Therefore, PTPlC may be a suitable candidate PTP to mediate the antiproliferative signals of SST. Our finding that OCT induces translocation of PTPlC from the cytosol to the membrane in a time-and concentration-dependent manner along with its G protein dependency strengthen this idea. Thus, SST-induced translocation of cytosolic PTPlC to the membrane appears to be an early and important event in the generation of its G protein-mediated antiproliferative signals. Anionic phospholipids have been reported to increase PTPlC activity (42). The activity of PTPlC recruited to the membrane by OCT is thus likely to be regulated by anionic lipids present in the membrane environment. Such a positive regulation may explain the greater increase (2.7-fold) in membrane-associated PTP activity compared to less than 2-fold decrease in intracellular PTP. Recruitment of PTPlC to the membranes has been shown to promote association through the SH2 domains to phosphorylated epidermal growth factor and erythropoietin receptors, leading to termination of mitogenic or proliferative signals through such receptors (38,43). We and others have shown that OCT induces apoptosis in tumor cells (11, 12) . Furthermore, both pertussis toxin and orthovanadate prevent OCT-induced apoptosis in AtT-20 mouse pituitary and MCF-7 human breast tumor cells (Srikant, C. B., unpublished observations). This combined with the present finding that these agents prevent OCT-induced translocation of PTPlC in MCF-7 cells suggest a possible role for PTPlC in the signaling cascade leading to apoptosis as well. The mechanism(s) by which PTPlC may signal SST-induced apoptosis remains to be elucidated. By attenuating mitogenic signaling, SST may be expected to inhibit the MAP kinase signaling cascade. However, the reported activation of MAP kinase by SST in a heterologous cell line expressing SSTR subtype 4 raises the question of whether a positive regulation of this pathway may occur in its antiproliferative signaling (44). In this context, it is interesting to note that ~38 MAP kinase activation has recently been reported to precede apoptosis induced by nerve growth factor withdrawal in PC-12 cells (45). A direct link between PTPlC and MAP kinase has not been demonstrated. It remains to be determined whether PTPs other than PTPlC play a role in SST-induced antiproliferative effects.
The inhibition of OCT-induced translocation of PTPlC by the phosphatase inhibitor orthovanadate has not previously been observed. At present, we do not know whether orthovanadate, an inhibitor of PTP, directly blocks the translocation of cytosolic PTPlC to the membrane. The possibility exists that prevention of OCT-induced translocation of PTPlC by orthovanadate may also result by an indirect mechanism dependent on its other cellular effects, such as inhibition of adenosine triphosphatase activity (46).
Five distinct SSTR subtypes, SSTRs l-5, have been cloned from human (h), mouse (m), and rat (r) tissues (for review, see Refs. 13 and 14) . The pharmacological profiles of the hSSTR subtypes expressed in Chinese hamster ovary (CHO)-Kl cells have allowed distinction of two subfamilies of SSTRs (13, 14, 47) . Cyclic hexa-and octapeptide SST analogs bind to the first group, consisting of hSSTR2, -3, and -5, but they do not bind to the other subset, comprising SSTRl and -4. It is, thus, likely that the antiproliferative action of SST peptides 
